Bioprox Healthcare leverages its industrial team’s expertise, advanced fermentation equipment, and 45 years of experience to assess the feasibility of your project and optimize the production of your proprietary strains.
Bioprox operates a dedicated, high-capacity facility for biomass production including:
- Fermentation
- Concentration
- Freeze-drying
- Formulation
—
Development studies to optimize cultivation conditions of novel strains.
—
Stability enhancement of freeze-dried powder
—
Fermenters up to 30 L
—
Intermediate step in industrial scale-up
—
Possibility to obtain an initial quantity of freeze dried powder for validations and clinical trials
—
Fermenters up to 1,000 L
—
Freeze-dried powder produced at an industrial scale with reproducible quality, formulated as single strains or blends, protected by triple foil bags.
—
Fermenters up to 10,000 L
—
Integration of state-of-the-art technologies to maximize productivity.
In case of a tech transfer, Bioprox Healthcare guarantees strict adherence to your manufacturing processes while fully safeguarding your proprietary know-how.
In case of tech transfer, Bioprox Healthcare ensures precise adherence to your manufacturing processes, while safeguarding and respecting your proprietary know-how.
Our CMO and CDMO services deliver best-in-class production performance while meeting your quality requirements (specifications, stability, etc.) for probiotics used in nutraceuticals, food, pet food, and cosmetics.
Interested?
S.svg){kind=logo}